赫拉
生物
CDKN2A
外显子组测序
杂合子丢失
外显子组
ARID1A型
梅克尔多元癌细胞病毒
癌症研究
克拉斯
遗传学
突变
癌症
癌
基因
梅克尔细胞癌
等位基因
作者
Sun Shin,Hyeon‐Chun Park,Min Sung Kim,Mi Seon Han,Sung Hak Lee,Seung‐Hyun Jung,Sug Hyung Lee,Yeun–Jun Chung
标识
DOI:10.1016/j.humpath.2018.03.008
摘要
Anal squamous cell carcinoma (ASCC), either with human papillomavirus (+) or (−), is a neoplastic disease with frequent recurrence and metastasis. To characterize ASCC genomes, we attempted to disclose novel alterations of ASCC genomes and other genetic features including mutation signatures. We performed whole-exome sequencing and copy number alteration (CNA) profiling for 8 ASCC samples from 6 patients (2 cases with primary and recurrent/metastatic tumors). We found known ASCC mutations (TP53, CDKN2A, and PIK3CA) and CNAs (gains on 3q and 19q and losses on 11q and 13q). In addition, we discovered novel mutations in HRAS and ARID1A and CNAs (gain on 8q and losses 5q, 9p, 10q, and 19p) that had not been reported in ASCCs. We identified 4 signature patterns of the mutations (signatures 1 and 2 with deamination of 5-methyl-cytosin, signature 3 with APOBEC, and signature 4 with mismatch repair) in the ASCCs. Although signatures 1 to 3 have been detected in other SCCs, signature 4 was first identified in ASCCs. In addition, we first found that ASCCs harbored chromothripsis, copy-neutral losses of heterozygosity, and focal amplification of KLF5 super-enhancer. Analyses of primary and recurrent/metastatic pair genomes revealed that driver events in development and progression of ASCC might not be uniform. Our data indicate that ASCCs may have similar mutation and CNA profiles to other SCCs, but that there are unique genomic features of ASCCs as well. Our data may provide useful information for ASCC pathogenesis and for developing clinical strategies for ASCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI